Table 1 Comparison of basic clinical characteristics between the two groups.

From: Impact of preoperative antidepressant use on surgical and functional outcomes of robot assisted radical prostatectomy

 

Control group (n = 125)

Intervention group (n = 80)

P value

Age, yr

66.42 ± 6.59

66.80 ± 5.85

0.67

BMI, kg/m2

25.73(21.20,29.30)

24.15(21.00,29.00)

0.38

Alcohol history

  

0.38

No

84(67.20)

49(61.25)

 

Yes

41(32.80)

31(38.75)

 

Smoking history

  

0.26

No

74(59.20)

41(51.25)

 

Yes

51(40.80)

39(48.75)

 

Initial PSA, ng/ml

11.60(7.50,16.90)

11.15(5.70,17.20)

0.29

Volume, ml

25.00(23.00,28.00)

25.50(23.00,28.00)

0.64

T stage, n

   

T1

64(51.20)

46(57.50)

0.54

T2

35(28.00)

22(27.50)

 

T3

26(20.80)

12(15.00)

 

Gleason

  

0.79

\(\leqq\)6

25(20.00)

14(17.50)

 

7

55(44.00)

39(48.75)

 

\(\geqq\)8

45(36.00)

27(33.75)

 

Postoperative ADT

9(7.20)

6(7.50)

0.94

Postoperative RT

7(5.60)

4(5.00)

0.85

Postoperative Chemo

12(9.60)

8(10.00)

0.93

Preoperative SDS, score

33.00(26.50,41.00)

58.00(52.0,64.8)

< 0.01

Preoperative IPSS, score

11.00(5.00,13.50)

10.50(5.00,16.00)

0.36

Preoperative SF-36-VT, score

47.00(42.00,53.00)

33.00(28.00,36.80)

<0.01

Preoperative PHQ, score

6.00(3.00,11.00)

9.50(6.00,13.00)

<0.01

  1. BMI, body mass index; PSA, Prostate-specific antigen; ADT, Androgen Deprivation Therapy; RT, Radiotherapy; Chemo, Chemotherapy; SDS, Self-Rating Depression Scale; IPSS, International Prostate Symptom Score; SF-36VT, Short Form 36 Health Survey’ s Vitality; PHQ, Patient Health Questionnaire.
  2. Continuous variables that follow a normal distribution are presented as Mean ± SD; otherwise, they are expressed as Median (Q1, Q3). Categorical variables are presented as n (%).
Back to article page